Home › Funds › BAKER BROS. ADVISORS LP › IMVT
BAKER BROS. ADVISORS LP position in IMVT
IMMUNOVANT INC COM · Health Care
BAKER BROS. ADVISORS LP reported holding 5,435,220 shares of IMVT (IMMUNOVANT INC COM) in its Q2 2026 13F filing — a position valued at US$209.4M, representing 1.09% of its reported portfolio and ranking #15 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's IMVT position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in IMVT in Q3 2023 at 425,009 shares (US$16.3M). The position peaked in Q2 2026 at 5,435,220 shares, worth US$209.4M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 5,435,220 shares valued at US$209.4M. Notable position changes include a 164% increase in Q3 2024 (shares fell 13% over the following quarter), a 39% increase in Q4 2024 (shares fell 31% over the following quarter), a 220% increase in Q1 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 425.01K | $16.32M | New |
| Q4 2023 | 425.01K | $17.91M | Hold |
| Q1 2024 | 425.01K | $13.73M | Hold |
| Q2 2024 | 464.72K | $12.27M | Add |
| Q3 2024 | 1.23M | $34.94M | Add |
| Q4 2024 | 1.71M | $42.30M | Add |
| Q1 2025 | 5.46M | $93.28M | Add |
| Q2 2025 | 5.46M | $87.33M | Hold |
| Q3 2025 | 5.46M | $87.98M | Hold |
| Q4 2025 | 5.46M | $138.74M | Hold |
| Q1 2026 | 5.46M | $135.57M | Hold |
| Q2 2026 | 5.44M | $209.42M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC COM) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.34M sh · $359.91M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.80M sh · $223.67M · Q2 2026
- TCG Crossover Management, LLC 4.46M sh · $171.77M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- RTW INVESTMENTS, LP 3.18M sh · $122.44M · Q2 2026
- ADAR1 Capital Management, LLC 2.33M sh · $89.80M · Q2 2026
- Alpine Global Management, LLC 1.38M sh · $52.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $46.24M · Q2 2026
- Logos Global Management LP 665.00K sh · $25.62M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 619.10K sh · $23.85M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held IMVT?
BAKER BROS. ADVISORS LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in IMVT?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 5.44M shares of IMVT (IMMUNOVANT INC COM), valued at $209.42M, representing 1.09% of its reported portfolio and ranking #15.
Has BAKER BROS. ADVISORS LP been buying or selling IMVT?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in IMVT. The position peaked in Q2 2026 at 5.44M shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.